Some joint soreness should not wait

New weakness or severe swelling needs quick care

Seek medical care promptly if the joint becomes hot, red, swollen, and very sore. Don't wait for a fever, since infection may be present without one.

New numbness, weakness, or loss of bladder or bowel control can involve nerves and shouldn't wait until the next open clinic appointment later in the week. A cold or pale limb after an injury also needs urgent care.

Sudden trouble seeing, along with head or jaw pain, can mean swollen blood vessels. It can threaten your sight, so get medical help at once.

Urgent problems come before a planned clinic visit

A doctor must first rule out infection, a break, or another urgent cause. After that, QC Kinetix can discuss planned, non-surgical care for the soreness.

Its regenerative treatments start with blood drawn at the clinic. Medical providers means the doctors or nurses who'll examine you and explain whether that care may fit.

For platelet-rich plasma, the blood is spun so more platelets collect together. The portion holding them is then placed into the sore joint.

The aim is to ease the ache and help the joint move, but improvement isn't certain. Ask how often you'll return, then ask the cost for all visits.

Find out what follow-up is included before care begins. That can spare you another drive and an unwelcome bill.

Ongoing loss of motion deserves an exam

Home care is reasonable when mild soreness follows extra work and improves with rest. Keep easy motion, but don't repeat the hard task just to test the joint.

Arrange a visit when swelling grows, sleep keeps breaking, or daily chores get harder. Soreness that reaches other joints shouldn't go without an exam.

Tell the doctor or nurse when each change started and what brings relief. Clear details can help you get suitable care sooner.

Sources

1. In a structured review of 14 studies covering 6,242 patients with an acutely painful swollen joint (653 with confirmed septic arthritis), no single symptom rules the diagnosis in or out: joint pain was present in 85%, a history of joint swelling in 78%, and fever in only 57%. The most powerful bedside data came from aspirating the joint - the summary likelihood ratio rose with the synovial fluid white cell count, from 0.32 below 25,000/microL to 2.9 at 25,000 or more, 7.7 above 50,000 and 28.0 above 100,000.

   Margaretten ME, Kohlwes J, Moore D, Bent S — Does this adult patient have septic arthritis?. JAMA, 2007. DOI: 10.1001/jama.297.13.1478.

2. A EULAR task force of 18 rheumatologists, 3 health professionals, 2 patients and a methodologist defined which joint symptoms, in the absence of any visible swelling, should make a clinician suspect that inflammatory arthritis is coming. Seven parameters survived: symptom duration under one year, symptoms in the knuckle (metacarpophalangeal) joints, morning stiffness lasting 60 minutes or more, symptoms worst in the early morning, a first-degree relative with rheumatoid arthritis, difficulty making a fist, and a positive squeeze test of the knuckles. The combination identified at-risk patients with an area under the ROC curve of 0.92 (95% CI 0.87-0.96).

   van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJJ, et al. — EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.. Annals of the Rheumatic Diseases, 2017. DOI: 10.1136/annrheumdis-2016-209846.

3. The 2012 EULAR/ACR provisional criteria for polymyalgia rheumatica were derived from a 6-month prospective cohort of 125 new-onset PMR patients and 169 comparison subjects with PMR mimics. The scoring algorithm gives 2 points for morning stiffness over 45 minutes, 1 for hip pain or restricted range, 2 for absence of rheumatoid factor and/or ACPA, and 1 for absence of peripheral joint pain. A score of 4 or more gave 68% sensitivity and 78% specificity overall, rising to 88% specificity against shoulder conditions but falling to 65% against rheumatoid arthritis. The authors state explicitly that these criteria are not meant for diagnostic purposes.

   Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. — 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.. Annals of the Rheumatic Diseases, 2012. DOI: 10.1136/annrheumdis-2011-200329.

4. In a matched case-control study of 40 early rheumatoid arthritis patients followed for 36 months, those who started DMARD therapy at a median disease duration of 3 months improved significantly more than those who started at 12 months. At study end the DAS28 had improved by 2.8 (SD 1.5) in the very-early group versus 1.7 (SD 1.2) in the late-early group, and radiographic joint destruction by Larsen score progressed significantly more slowly in the very-early group.

   Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS — Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.. Rheumatology (Oxford), 2004. DOI: 10.1093/rheumatology/keh199.

5. Axial spondyloarthritis affects roughly 1% of the US population and is characteristically missed. Population prevalence (0.9-1.4%) is well above diagnosed prevalence (0.2-0.7%), the estimated US diagnostic delay is 14 years, and only 37% of US ankylosing spondylitis patients are diagnosed by a rheumatologist - the other 63% by primary care (26%), chiropractic or physical therapy (7%), orthopedic surgery (4%), pain clinics (4%), acute care (3%) and other settings (19%).

   Danve A, Deodhar A — Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities.. Clinical Rheumatology, 2019. DOI: 10.1007/s10067-018-4397-3.